1. |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2021, 71(3): 209-249.
|
2. |
Breiteneder-Geleff S, Soleiman A, Kowalski H, et al. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am J Pathol, 1999, 154(2): 385-394.
|
3. |
Schacht V, Ramirez MI, Hong YK, et al. T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. EMBO J, 2003, 22(14): 3546-3556.
|
4. |
Uhrin P, Zaujec J, Breuss JM, et al. Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation. Blood, 2010, 115(19): 3997-4005.
|
5. |
Honma M, Minami-Hori M, Takahashi H, et al. Podoplanin expression in wound and hyperproliferative psoriatic epidermis: regulation by TGF-β and STAT-3 activating cytokines, IFN-γ, IL-6, and IL-22. J Dermatol Sci, 2012, 65(2): 134-140.
|
6. |
Peters A, Pitcher LA, Sullivan JM, et al. Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation. Immunity, 2011, 35(6): 986-996.
|
7. |
Miyamoto Y, Uga H, Tanaka S, et al. Podoplanin is an inflammatory protein upregulated in Th17 cells in SKG arthritic joints. Mol Immunol, 2013, 54(2): 199-207.
|
8. |
Zhu X, Xu M, Zhao X, et al. The detection of plasma soluble podoplanin of patients with breast cancer and its clinical signification. Cancer Manag Res, 2020, 12: 13207-13214.
|
9. |
Xu M, Wang X, Pan Y, et al. Blocking podoplanin suppresses growth and pulmonary metastasis of human malignant melanoma. BMC Cancer, 2019, 19(1): 599. doi: 10.1186/s12885-019-5808-9.
|
10. |
Shibahara J, Kashima T, Kikuchi Y, et al. Podoplanin is expressed in subsets of tumors of the central nervous system. Virchows Arch, 2006, 448(4): 493-499.
|
11. |
Brown KM, Domin C, Aranha GV, et al. Increased preoperative platelet count is associated with decreased survival after resection for adenocarcinoma of the pancreas. Am J Surg, 2005, 189(3): 278-282.
|
12. |
Ayhan A, Bozdag G, Taskiran C, et al. The value of preoperative platelet count in the prediction of cervical involvement and poor prognostic variables in patients with endometrial carcinoma. Gynecol Oncol, 2006, 103(3): 902-905.
|
13. |
赵星鹏, 赵益明. 平足蛋白生物学功能的研究进展与应用前景. 肿瘤研究与临床, 2016, 28(9): 634-637.
|
14. |
Krishnan H, Miller WT, Blanco FJ, et al. Src and podoplanin forge a path to destruction. Drug Discov Today, 2019, 24(1): 241-249.
|
15. |
Eisemann T, Costa B, Harter PN, et al. Podoplanin expression is a prognostic biomarker but may be dispensable for the malignancy of glioblastoma. Neuro Oncol, 2019, 21(3): 326-336.
|
16. |
Tesfamariam B. Involvement of platelets in tumor cell metastasis. Pharmacol Ther, 2016, 157: 112-119.
|
17. |
La Vecchia S, Sebastián C. Metabolic pathways regulating colorectal cancer initiation and progression. Semin Cell Dev Biol, 2020, 98: 63-70.
|
18. |
Lowe KL, Navarro-Nunez L, Watson SP. Platelet CLEC-2 and podoplanin in cancer metastasis. Thromb Res, 2012, 129 Suppl 1: S30-S37.
|
19. |
Yao L, Liu Z, Zhu J, et al. Clinical evaluation of circulating microRNA-25 level change in sepsis and its potential relationship with oxidative stress. Int J Clin Exp Pathol, 2015, 8(7): 7675-7684.
|
20. |
Parhar S, Kaur H, Vashist A, et al. Role of podoplanin in potentially malignant disorders and oral squamous cell carcinoma and its correlation with lymphangiogenesis. Indian J Cancer, 2015, 52(4): 617-622.
|
21. |
Carrasco-Ramírez P, Greening DW, Andrés G, et al. Podoplanin is a component of extracellular vesicles that reprograms cell-derived exosomal proteins and modulates lymphatic vessel formation. Oncotarget, 2016, 7(13): 16070-16089.
|
22. |
Yeung KT, Yang J. Epithelial-mesenchymal transition in tumor metastasis. Mol Oncol, 2017, 11(1): 28-39.
|
23. |
Ito S, Ishii G, Hoshino A, et al. Tumor promoting effect of podoplanin-positive fibroblasts is mediated by enhanced RhoA activity. Biochem Biophys Res Commun, 2012, 422(1): 194-199.
|
24. |
Suzuki H, Onimaru M, Yonemitsu Y, et al. Podoplanin in cancer cells is experimentally able to attenuate prolymphangiogenic and lymphogenous metastatic potentials of lung squamoid cancer cells. Mol Cancer, 2010, 9: 287. doi: 10.1186/1476-4598-9-287.
|
25. |
Chihara N, Madi A, Kondo T, et al. Induction and transcriptional regulation of the co-inhibitory gene module in T cells. Nature, 2018, 558(7710): 454-459.
|